IBDEI0SW ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13550,1,4,0)
 ;;=4^C91.02
 ;;^UTILITY(U,$J,358.3,13550,2)
 ;;=^5001764
 ;;^UTILITY(U,$J,358.3,13551,0)
 ;;=C92.02^^53^593^6
 ;;^UTILITY(U,$J,358.3,13551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13551,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,13551,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,13551,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,13552,0)
 ;;=D09.3^^53^593^45
 ;;^UTILITY(U,$J,358.3,13552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13552,1,3,0)
 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
 ;;^UTILITY(U,$J,358.3,13552,1,4,0)
 ;;=4^D09.3
 ;;^UTILITY(U,$J,358.3,13552,2)
 ;;=^5001955
 ;;^UTILITY(U,$J,358.3,13553,0)
 ;;=C22.0^^53^593^86
 ;;^UTILITY(U,$J,358.3,13553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13553,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,13553,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,13553,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,13554,0)
 ;;=C24.9^^53^593^110
 ;;^UTILITY(U,$J,358.3,13554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13554,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,13554,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,13554,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,13555,0)
 ;;=C50.922^^53^593^134
 ;;^UTILITY(U,$J,358.3,13555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13555,1,3,0)
 ;;=3^Malig Neop Left Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,13555,1,4,0)
 ;;=4^C50.922
 ;;^UTILITY(U,$J,358.3,13555,2)
 ;;=^5133340
 ;;^UTILITY(U,$J,358.3,13556,0)
 ;;=C34.91^^53^593^152
 ;;^UTILITY(U,$J,358.3,13556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13556,1,3,0)
 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,13556,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,13556,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,13557,0)
 ;;=C50.921^^53^593^156
 ;;^UTILITY(U,$J,358.3,13557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13557,1,3,0)
 ;;=3^Malig Neop Right Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,13557,1,4,0)
 ;;=4^C50.921
 ;;^UTILITY(U,$J,358.3,13557,2)
 ;;=^5001198
 ;;^UTILITY(U,$J,358.3,13558,0)
 ;;=C90.02^^53^593^167
 ;;^UTILITY(U,$J,358.3,13558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13558,1,3,0)
 ;;=3^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,13558,1,4,0)
 ;;=4^C90.02
 ;;^UTILITY(U,$J,358.3,13558,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,13559,0)
 ;;=D51.9^^53^593^25
 ;;^UTILITY(U,$J,358.3,13559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13559,1,3,0)
 ;;=3^Anemia in Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,13559,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,13559,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,13560,0)
 ;;=C79.51^^53^593^30
 ;;^UTILITY(U,$J,358.3,13560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13560,1,3,0)
 ;;=3^Bone Mets
 ;;^UTILITY(U,$J,358.3,13560,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,13560,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,13561,0)
 ;;=C80.1^^53^593^163
 ;;^UTILITY(U,$J,358.3,13561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13561,1,3,0)
 ;;=3^Malig Neop,Primary,Unspec Site
 ;;^UTILITY(U,$J,358.3,13561,1,4,0)
 ;;=4^C80.1
 ;;^UTILITY(U,$J,358.3,13561,2)
 ;;=^5001389
 ;;^UTILITY(U,$J,358.3,13562,0)
 ;;=C80.0^^53^593^164
 ;;^UTILITY(U,$J,358.3,13562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13562,1,3,0)
 ;;=3^Malig Neop,Unspec Primary or Secondary
 ;;^UTILITY(U,$J,358.3,13562,1,4,0)
 ;;=4^C80.0
 ;;^UTILITY(U,$J,358.3,13562,2)
 ;;=^5001388
 ;;^UTILITY(U,$J,358.3,13563,0)
 ;;=Z85.818^^53^594^92
 ;;^UTILITY(U,$J,358.3,13563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13563,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx
